Decheng Capital Management III (Cayman), LLC - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 75 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Decheng Capital Management III (Cayman), LLC ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q2 2022$76,000
-39.7%
20,0000.0%0.03%
-25.6%
Q1 2022$126,00020,0000.04%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q3 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,112,019$250,398,0004.45%
Casdin Capital, LLC 2,692,870$74,000,0001.88%
Perceptive Advisors 6,165,740$169,434,0001.10%
Nicholas Investment Partners, LP 629,716$17,305,0001.08%
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. 3,440$95,0000.71%
Orbimed Advisors 1,998,521$54,919,0000.56%
Alphabet Inc. 646,622$17,769,0000.36%
Pinz Capital Management, LP 36,400$1,000,0000.30%
NEXPOINT ASSET MANAGEMENT, L.P. 39,142$1,076,0000.24%
Coatue Management 2,119,614$58,247,0000.23%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders